Chris P Gale
A5054578676- Acute Myocardial Infarction Research
- Heart Failure Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Function and Risk Factors
- Cardiac Health and Mental Health
- COVID-19 and healthcare impacts
- Cardiac pacing and defibrillation studies
- Healthcare cost, quality, practices
- Antiplatelet Therapy and Cardiovascular Diseases
- Coronary Interventions and Diagnostics
- Cardiac Arrhythmias and Treatments
- COVID-19 Clinical Research Studies
- Lipoproteins and Cardiovascular Health
- Blood Pressure and Hypertension Studies
- Venous Thromboembolism Diagnosis and Management
- Cardiac Arrest and Resuscitation
- Healthcare Policy and Management
- Chronic Disease Management Strategies
- Acute Ischemic Stroke Management
- Frailty in Older Adults
- Cardiac Valve Diseases and Treatments
- Cardiac electrophysiology and arrhythmias
University of Leeds
2016-2025
Leeds Teaching Hospitals NHS Trust
2011-2025
Leeds General Infirmary
2004-2024
Kyoto University
2024
Imperial College Healthcare NHS Trust
2024
Imperial College London
2024
University of Otago
2021-2023
Paris Cardiovascular Research Center
2023
Hôpital Européen Georges-Pompidou
2023
Duke University
2023
Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It also read 60 mginstead mg (use with caution in 'supranormal' renal function).In the above-indicated cell, a footnote has been added to state: Edoxaban used patients high creatinine clearance only after careful evaluation individual thromboembolic and bleeding risk.Supplementary 'Dose reduction selected patients' 16). reduced 30 once daily if any...
The ESC/EAS Guidelines represent the views of ESC and EAS, were produced after careful consideration scientific medical knowledge, evidence available at time their publication.The EAS is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when...
Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This can be modified lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve stabilization regression. The have long, stable periods but also become unstable at any time, typically due an acute atherothrombotic event caused rupture erosion. However, chronic, most often...
A correction has been published: European Heart Journal, ehaa895, https://doi.org/10.1093/eurheartj/ehaa895
Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing best management strategies for an individual patient a given condition. their recommendations should facilitate decision making daily practice. However, final decisions concerning must be made by responsible professional(s) consultation caregiver as appropriate.
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
BackgroundThe contemporary associations of type 2 diabetes with a wide range incident cardiovascular diseases have not been compared. We aimed to study between and 12 initial manifestations disease.MethodsWe used linked primary care, hospital admission, disease registry, death certificate records from the CALIBER programme, which links data for people in England recorded four electronic health sources. included who were (or turned) 30 years or older Jan 1, 1998, March 25, 2010, free at...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge, evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
Abstract Aims The 2019 report from the European Society of Cardiology (ESC) Atlas provides a contemporary analysis cardiovascular disease (CVD) statistics across 56 member countries, with particular emphasis on international inequalities in burden and healthcare delivery together estimates progress towards meeting 2025 World Health Organization (WHO) non-communicable targets. Methods results In this report, CVD are presented for countries ESC. drawn ESC which is repository data variety...
Abstract Aims This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon widely cited 2019 in presenting cardiovascular disease (CVD) statistics for 57 ESC member countries. Methods results Statistics pertaining to 2019, or latest available year, are presented. Data sources include World Health Organization, Institute Metrics Evaluation, Bank, novel sponsored data on human capital infrastructure healthcare delivery. New material this includes...
The European Society of Cardiology (ESC) Atlas has been compiled by the Heart Agency to document cardiovascular disease (CVD) statistics 56 ESC member countries. A major aim this 2017 data presentation compare high-income and middle-income countries identify inequalities in burden, outcomes, service provision. utilizes a variety sources, including World Health Organization, Institute for Metrics Evaluation, Bank risk factors, prevalence, mortality national economic indicators. It also...
Several countries affected by the COVID-19 pandemic have reported a substantial drop in number of patients attending emergency department with acute coronary syndromes and reduced cardiac procedures. We aimed to understand scale, nature, duration changes admissions for different types syndrome England evaluate whether in-hospital management has been as result pandemic.We analysed data on hospital from Jan 1, 2019, May 24, 2020, that were recorded Secondary Uses Service Admitted Patient Care...
The EURO-ENDO registry aimed to study the management and outcomes of patients with infective endocarditis (IE).Prospective cohort 3116 adult (2470 from Europe, 646 non-ESC countries), admitted 156 hospitals in 40 countries between January 2016 March 2018 a diagnosis IE based on ESC 2015 diagnostic criteria. Clinical, biological, microbiological, imaging [echocardiography, computed tomography (CT) scan, 18F-fluorodeoxyglucose positron emission tomography/computed (18F-FDG PET/CT)] data were...
The COVID-19 pandemic required a significant redeployment of worldwide healthcare resources. Fear infection, national lockdowns and altered priorities have the potential to impact utilisation resources for non-communicable diseases. To survey health professionals' views on rate timing admission patients with ST-elevation myocardial infarction (STEMI), European Society Cardiology (ESC) administered an internet-based questionnaire cardiologists cardiovascular nurses across 6 continents. 3101...
For acute myocardial infarction (AMI) without heart failure (HF), it is unclear if β-blockers are associated with reduced mortality. The goal of this study was to determine the association between β-blocker use and mortality in patients AMI HF or left ventricular systolic dysfunction (LVSD). This cohort used national English Welsh registry data from Myocardial Ischaemia National Audit Project. A total 179,810 survivors hospitalization LVSD, January 1, 2007, June 30, 2013 (final follow-up:...
This study assessed sex differences in treatments, all-cause mortality, relative survival, and excess mortality following acute myocardial infarction.A population-based cohort of all hospitals providing infarction care Sweden (SWEDEHEART [Swedish Web System for Enhancement Development Evidence-Based Care Heart Disease Evaluated According to Recommended Therapies]) from 2003 2013 was included the analysis. Excess rate ratios (EMRRs), adjusted clinical characteristics guideline-indicated...